Australia markets closed

bioMérieux S.A. (0RUG.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
104.40-0.97 (-0.92%)
At close: 08:30AM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 312.65%
S&P500 52-week change 326.76%
52-week high 3104.75
52-week low 377.50
50-day moving average 393.95
200-day moving average 395.32

Share statistics

Avg vol (3-month) 352.23k
Avg vol (10-day) 332.76k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 843.73M
% held by insiders 163.59%
% held by institutions 120.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.85
Trailing annual dividend yield 30.81%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 320 Sept 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 10.81%
Operating margin (ttm)15.16%

Management effectiveness

Return on assets (ttm)7.08%
Return on equity (ttm)10.61%

Income statement

Revenue (ttm)3.81B
Revenue per share (ttm)32.26
Quarterly revenue growth (yoy)7.40%
Gross profit (ttm)N/A
EBITDA 863.5M
Net income avi to common (ttm)411.3M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)33.20%

Balance sheet

Total cash (mrq)272.2M
Total cash per share (mrq)2.31
Total debt (mrq)558.5M
Total debt/equity (mrq)14.39%
Current ratio (mrq)2.21
Book value per share (mrq)32.78

Cash flow statement

Operating cash flow (ttm)494.6M
Levered free cash flow (ttm)180.71M